Status: New
| Name & address of the Laboratory/Organization | ICAR-Central Institute Brackishwater Aquaculture, Chennai | |
| Website address | https://ciba.icar.gov.in | |
| Affiliated to which Department/Ministry | Indian Council of Agricultural Research (ICAR) | |
| CSR Registration Number | NA | |
| Registration under 12A | ||
| Registration under 80G | ||
| Name of the CSR Nodal | R.Geetha, Senior Scientist, ICAR-CIBA. | |
| Contact information of CSR Nodal | sathishkumar.t@icar.gov.in, sathishkumar.t@icar.gov.in | |
| Principal Investigator | T. Sathish Kumar, sathishkumar.t@icar.gov.in https://ciba.icar.gov.in |
|
| Co- Principal Investigator (Co-PI) | , mary.r@icar.gov.in | |
| Objective on the basis of need | To assess the efficacy of ‘CIBA EHP cura I’ in the treatment of EHP in shrimp culture. • To evaluate the impact of ‘CIBA EHP cura I’ in shrimp growth, health and productivity. • To promote capacity building among shrimp farmers on sustainable shrimp farming practices by reducing the disease outbreaks and the usage of chemicals. • To disseminate success stories and promote technology adoption of ‘CIBA EHP cura I’ among stakeholders. |
| Executive summary of the proposed project (In 250 words) | Shrimp aquaculture is the fastest growing food producing sector making major contribution in nation’s foreign exchange revenue. Diseases are the major concern in the sustainable growth of shrimp aquaculture. EHP (Enterocytozzon hepatopenaei) the shrimp microsporidian poses a significant threat to the global shrimp aquaculture. EHP is the causative agent of the disease hepatopancreatic microsporidiasis (HPM). EHP is reported to be associated with size variation/ growth retardation and white feces syndrome (WFS). The production loss due to EHP infection in Indian shrimp farms were estimated to be 0.77 M tonnes with a revenue loss of around Rs 4000 crores. In this context, developing treatment and therapeutics protocol against EHP is crucial for the effective management of EHP infection in shrimp farms. However, the studies on therapeutics and treatment against EHP are very limited. Recently, ICAR-CIBA developed a natural plant-based therepeutic ‘CIBA EHP cura I’ for the treatment of EHP. ‘CIBA EHP cura I’ is found to be promising in experimental laboratory studies and field validation. ‘CIBA EHP cura I’ had been commercialized to three private partners and the technology had been released during 96th ICAR foundation day. A large-scale demonstration of this product is necessary to create widespread awareness and adoption among the shrimp farmers which may aid in the effective management of EHP and reducing disease related losses. |
| Technology Readiness Level (If not a new project but an advancement of existing know how) | New Project |
| Outomes or Deliverables | Increased farmer understanding about EHP and its control • Reduced EHP infection level in treatment ponds. • Improved shrimp health, growth, survival and overall productivity • Increased awareness among the farmers for the adoption of CURA and sustainable, health management practices. • Dissemination of success stories to encourage wider adoption of the technology. |
| Project aligned with which most relevant UN SDGs | Goal 12 - Responsible Consumption & Production |
| Duration (In years) | Two years |
| Expected Impact | 1. Reduction in economic losses due to EHP 2. Improved shrimp health and farmer's income 3.Sustainable shrimp farming 4.Enhanced farmer awareness |
| Implementation model (self- implemented/ outsourced partnership) | Self implemented |
| Total Budget (Recurring +Non-Recurring Expenses) | 61.4 lakhs |
| Attachment | View Attachment |